Drug Profile
Amikacin liposomal - SkyePharma
Alternative Names: DepoAmikacin™Latest Information Update: 25 Sep 2021
Price :
$50
*
At a glance
- Originator SkyePharma Inc
- Class Aminoglycosides; Anti-infectives; Antibacterials; Small molecules
- Mechanism of Action Protein 30S ribosomal subunit inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Postoperative infections
Most Recent Events
- 29 May 2002 Discontinued - Phase-I for Postoperative infections in USA (Parenteral)
- 14 Feb 2000 DepoTech is now called SkyePharma Inc
- 07 Dec 1999 Phase-I clinical trials for Postoperative infections in USA (Parenteral)